PATENT CLAIM ANALYSIS

Application Number: 16247132
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["546", "113000"]

Abstract:
The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R 1  to R 5  are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.

Claim (Index 3):
A compound according to  claim 2 , wherein:\n R 1  is cyclopentyl, dioxothiadiazolidinyl, benzyldioxothiadiazolidinyl, dioxothiadiazolidinyl, oxomorpholinyl, dimethyloxooxazolidinyl, oxopyrrolidinyl, cyanooxopyrrolidinyl, methyloxadiazolyloxopyrrolidinyl, difluorophenyl or fluoropyridinyl; R 2  is H; R 3  is cyanofluorophenyl, methylfluorophenyl, trifluorophenyl, trifluoromethylfluorophenyl, fluoropyridinyl, difluoropyridinyl or thienyl; R 4  is H; R 5  is H; or a pharmaceutically acceptable salt, enantiomer or diastereomer thereof.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 99.0
- Lexical Diversity: 1.28205
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14997346', '16247170', '16196324', '16247084', '14632078']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.803983359123152
- 35 USC 102 Novelty (BERT): 0.5812700459750796
- Combined Prediction Score: 0.7817120278083448
- Mean Citation Score: 415.54647000000006
- Max Citation Score: 473.76462
- Similarity Product: 428.25499869170665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test